Saudi Crown Prince Launches National Biotechnology Strategy

Saudi Crown Prince Mohammed bin Salman bin Abdulaziz Al-Saud. SPA
Saudi Crown Prince Mohammed bin Salman bin Abdulaziz Al-Saud. SPA
TT
20

Saudi Crown Prince Launches National Biotechnology Strategy

Saudi Crown Prince Mohammed bin Salman bin Abdulaziz Al-Saud. SPA
Saudi Crown Prince Mohammed bin Salman bin Abdulaziz Al-Saud. SPA

Saudi Crown Prince Mohammed bin Salman bin Abdulaziz Al-Saud has launched the National Biotechnology Strategy, a comprehensive roadmap designed to enhance the Kingdom's position as a leader in the sector.

The strategy is a key enabler that will strengthen national health resilience and promote growth in the fast-growing biotechnology sector. A document was released that outlines the vision for what is possible with the power of biotechnology and the steps that will be taken to harness its potential.
The National Biotechnology Strategy works to address challenges and seize opportunities in a rapidly growing sector, serving as a roadmap for becoming a global leader in biotechnology by 2040. The strategy focuses on enhancing the health and well-being of Saudi citizens, stimulating economic growth, creating skilled job opportunities, and attracting investments to foster new industries, all while promoting a sustainable environment and contributing to Vision 2030.
With the ambition of becoming the biotechnology leader in the MENA region by 2030 and a major international biotechnology hub by 2040, the National Biotechnology Strategy will build on the Kingdom’s existing strengths including access to robust capital, large market, government commitment and a unique gene pool, to advance its capabilities across four strategic plays: vaccines, bio-manufacturing & localization, genomics, and plant optimization.
The Kingdom recognizes the importance of vaccines and is committed to developing innovative vaccine technologies. By localizing vaccine manufacturing, the strategy aims to increase the Kingdom's self-sufficiency and ensure timely access to vaccines for its citizens. Localization and biomanufacturing play a vital role in driving the strategy forward, as Saudi Arabia aims to establish itself as the primary biotechnology hub in the MENA region.

Developing advanced biopharma manufacturing capabilities and establishing a cutting-edge local end-to-end bio-manufacturing platform are crucial steps. These endeavors contribute to the availability of life-saving treatments, strengthen the domestic biotechnology industry, and solidify the Kingdom's position as a significant player in the global biotechnology landscape.

Genomics is a disruptive field and the next frontier of medicine, and the Kingdom aspires to become the leading genomics player in MENA, driving innovation and improving health and wellbeing outcomes for its citizens and beyond.

The National Biotechnology Strategy also contributes to strengthening food security and sustainable agricultural productivity through plant optimization. By leveraging biotechnology, the strategy aims to reduce reliance on food imports and enhance domestic production, ensuring a more sustainable and self-sufficient food supply.
The evolution of a mature and functional biotechnology ecosystem in Saudi Arabia will be enabled by a set of initiatives that systematically address barriers across talent, regulation, funding, and infrastructure.

With a robust pipeline of programs and initiatives, the strategy will catalyze the growth of Saudi Arabia’s biotechnology sector and unify efforts in the ecosystem, creating high quality jobs by 2030, and exciting opportunities for investors and biotechnology talent.

This strategy marks a significant milestone for Saudi Arabia in becoming a major player in the regional and global biotechnology sector. It aims to contribute 3% of non-oil real GDP by 2040, thereby helping to deliver economic diversification. Through the successful implementation of this strategy, the Kingdom will establish a leading biotechnology hub that drives innovation, job creation, and economic growth.



Report: US Energy Chief Wright Heads to Middle East for Nearly Two Weeks

US Secretary of Energy Chris Wright speaks to the media, outside of the West Wing of the White House, in Washington, DC, US, March 19, 2025. (Reuters)
US Secretary of Energy Chris Wright speaks to the media, outside of the West Wing of the White House, in Washington, DC, US, March 19, 2025. (Reuters)
TT
20

Report: US Energy Chief Wright Heads to Middle East for Nearly Two Weeks

US Secretary of Energy Chris Wright speaks to the media, outside of the West Wing of the White House, in Washington, DC, US, March 19, 2025. (Reuters)
US Secretary of Energy Chris Wright speaks to the media, outside of the West Wing of the White House, in Washington, DC, US, March 19, 2025. (Reuters)

US Energy Secretary Chris Wright on Wednesday will launch a nearly two-week tour of three Middle East countries, including Saudi Arabia, a source familiar with the matter told Reuters.

The trip, which will also include visits to Qatar and the United Arab Emirates, is expected to help lay the groundwork for President Donald Trump's own visit to those countries likely in mid-May.

It comes at a critical time, on the heels of Trump's surprise announcement on Monday that the US and Iran are having direct talks on Tehran's nuclear program and as global oil prices hit a near four-year low.

Oil prices have fallen on worries that Trump's latest tariffs could push economies around the world into recession at the same time OPEC+ oil producers speed up increases in production.